TRIM65 and hepatocellular carcinoma: Previous studies have reported that TRIM65 contributes to the activation of the β‐catenin signaling pathway by ubiquitylation of axis inhibition protein 1 (Axin1) in HCC,[28] which is not consistent with the results of our study (Figure S4A, Supporting Information).